Skip to content
Search

Latest Stories

Britain misses Covid-19 testing target for fourth day running

The UK failed to meet its target of conducting 100,000 daily Covid-19 tests for a fourth day running, data released on Wednesday (6) showed, as questions persist over the way it briefly manage to do so at the end of April.

Last week, health minister Matt Hancock claimed victory in his quest to expand Britain's testing programme to 100,000 a day by the end of last month when he announced the government had conducted more than 122,000 tests on April 30.


However, in subsequent days the number has fallen back sharply. It dropped below 100,000 two days later and fell to a low of 69,463 in the 24 hours up to 0800 GMT on Wednesday.

The government has placed mass testing and contact-tracing at the top of its agenda as it seeks to unwind a nationwide lockdown, six weeks after ordering businesses to close and citizens to stay at home to slow the virus outbreak.

Capacity was expanded rapidly during April from a level of around 15,000 tests per day but political opponents have accused the government of manipulating the data in order to meet the closely watched month-end target.

They point to the fact that around 40,000 testing kits included in the April 30 figure were counted as completed tests at the point they were mailed out, not when they were actually returned or analysed.

The leader of the opposition Labour Party, Keir Starmer, speaking in parliament on Wednesday before the latest announcement, asked prime minister Boris Johnson why the data had temporarily spiked at the end of April.

Johnson responded by saying that the system remained capable of more than 100,000 tests per day but that capacity was higher than demand at the moment. He went on to announce a new target of 200,000 tests per day by the end of May.

An official later clarified that he had meant the capacity to conduct 200,000 tests per day, not 200,000 completed tests.

(Reuters)

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less